{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T01:56:55Z","timestamp":1793239015084,"version":"4.5.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T00:00:00Z","timestamp":1609977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T00:00:00Z","timestamp":1609977600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Liver fibrosis is a course of chronic liver dysfunction, can develop into cirrhosis and hepatocellular carcinoma. Inflammatory insult owing to pathogenic factors plays a crucial role in the pathogenesis of liver fibrosis. Indoleamine 2,3-dioxygenase 1 (IDO1) can affect the infiltration of immune cells in many pathology processes of diseases, but its role in liver fibrosis has not been elucidated completely. Here, the markedly elevated protein IDO1 in livers was identified, and dendritic cells (DCs) immune-phenotypes were significantly altered after BDL challenge. A distinct hepatic population of CD11c<jats:sup>+<\/jats:sup>DCs was decreased and presented an immature immune-phenotype, reflected by lower expression levels of co-stimulatory molecules (CD40, MHCII). Frequencies of CD11c<jats:sup>+<\/jats:sup>CD80<jats:sup>+<\/jats:sup>, CD11c<jats:sup>+<\/jats:sup>CD86<jats:sup>+<\/jats:sup>, CD11c<jats:sup>+<\/jats:sup>MHCII<jats:sup>+<\/jats:sup>, and CD11c<jats:sup>+<\/jats:sup>CD40<jats:sup>+<\/jats:sup>cells in splenic leukocytes were reduced significantly. Notably, IDO1 overexpression inhibited hepatic, splenic CD11c<jats:sup>+<\/jats:sup>DCs maturation, mature DCs-mediated T-cell proliferation and worsened liver fibrosis, whereas above pathological phenomena were reversed in IDO1<jats:sup>\u2212\/\u2212<\/jats:sup>mice. Our data demonstrate that IDO1 affects the process of immune cells recruitment via inhibiting DCs maturation and subsequent T cells proliferation, resulting in the promotion of hepatic fibrosis. Thus, amelioration of immune responses in hepatic and splenic microenvironment by targeting IDO1 might be essential for the therapeutic effects on liver fibrosis.<\/jats:p>","DOI":"10.1038\/s41419-020-03277-0","type":"journal-article","created":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T19:07:49Z","timestamp":1610046469000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Indoleamine 2,3-dioxygenase 1 limits hepatic inflammatory cells recruitment and promotes bile duct ligation-induced liver fibrosis"],"prefix":"10.1038","volume":"12","author":[{"given":"Chan","family":"Mo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuwen","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weichao","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sha","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqi","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanghui","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuying","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weixin","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaohui","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2791-2758","authenticated-orcid":false,"given":"Lei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiping","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,7]]},"reference":[{"key":"3277_CR1","volume":"53","author":"X Yang","year":"2020","unstructured":"Yang, X. et al. Curcumol attenuates liver sinusoidal endothelial cell angiogenesis via regulating Glis-PROX1-HIF-1\u03b1 in liver fibrosis. Cell Prolif. 53, e12762 (2020).","journal-title":"Cell Prolif."},{"key":"3277_CR2","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.ajpath.2019.11.012","volume":"190","author":"Z Zhou","year":"2020","unstructured":"Zhou, Z. et al. Toll-like receptor 5 signaling ameliorates liver fibrosis by inducing interferon \u03b2-modulated IL-1 receptor antagonist in mice. Am. J. Pathol. 190, 614\u2013629 (2020).","journal-title":"Am. J. Pathol."},{"key":"3277_CR3","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3748\/wjg.v26.i2.109","volume":"26","author":"S Tanwar","year":"2020","unstructured":"Tanwar, S., Rhodes, F., Srivastava, A., Trembling, P. M. & Rosenberg, W. M. Inflammation and fibrosis in chronic liver diseases including non-alcoholic fatty liver disease and hepatitis C. World J. Gastroenterol. 26, 109\u2013133 (2020).","journal-title":"World J. Gastroenterol."},{"key":"3277_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-14138-6","volume":"11","author":"J Zhou","year":"2020","unstructured":"Zhou, J. et al. SUMOylation inhibitors synergize with FXR agonists in combating liver fibrosis. Nat. Commun. 11, 240 (2020).","journal-title":"Nat. Commun."},{"key":"3277_CR5","doi-asserted-by":"crossref","unstructured":"Darmadi, D. & Ruslie, R. H. Endothelin-1 level as a predictor of hepatopulmonary syndrome in liver cirrhosis. Med. Glas (Zenica). 17, 389\u2013394 (2020).","DOI":"10.17392\/1177-20"},{"key":"3277_CR6","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jhep.2018.09.014","volume":"70","author":"SK Asrani","year":"2019","unstructured":"Asrani, S. K., Devarbhavi, H., Eaton, J. & Kamath, P. S. Burden of liver diseases in the world. J. Hepatol. 70, 151\u2013171 (2019).","journal-title":"J. Hepatol."},{"key":"3277_CR7","doi-asserted-by":"crossref","unstructured":"Yang, D. & Liu, J. Targeting extracellular vesicles-mediated hepatic inflammation as a therapeutic strategy in liver diseases. Liver Int. 40, 2064\u20132073 (2020).","DOI":"10.1111\/liv.14579"},{"key":"3277_CR8","doi-asserted-by":"publisher","unstructured":"Boeijen, L. L., Spaan, M. & Boonstra, A. The effects of nucleoside\/nucleotide analogues on host immune cells: the baseline for future immune therapy for HBV? Antivir. Ther. (2020). https:\/\/doi.org\/10.3851\/IMP3364. Epub ahead of print. PMID: 32589166.","DOI":"10.3851\/IMP3364"},{"key":"3277_CR9","doi-asserted-by":"publisher","first-page":"111556","DOI":"10.1016\/j.fct.2020.111556","volume":"143","author":"M Matsuda","year":"2020","unstructured":"Matsuda, M. & Seki, E. The liver fibrosis niche: novel insights into the interplay between fibrosis-composing mesenchymal cells, immune cells, endothelial cells, and extracellular matrix. Food Chem. Toxicol. 143, 111556 (2020).","journal-title":"Food Chem. Toxicol."},{"key":"3277_CR10","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1097\/MEG.0000000000001597","volume":"32","author":"C Triantos","year":"2020","unstructured":"Triantos, C. et al. Vitamin D-related immunomodulation in patients with liver cirrhosis. Eur. J. Gastroenterol. Hepatol. 32, 867\u2013876 (2020).","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"3277_CR11","doi-asserted-by":"publisher","unstructured":"Mondanelli, G. et al. A novel mutation of indoleamine 2,3-dioxygenase 1 causes a rapid proteasomal degradation and compromises protein function. J. Autoimmun. 115, 102509 (2020) https:\/\/doi.org\/10.1016\/j.jaut.2020.102509. Epub 2020 Jun 27. PMID: 32605792.","DOI":"10.1016\/j.jaut.2020.102509"},{"key":"3277_CR12","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1080\/14756366.2020.1765165","volume":"35","author":"S Ge","year":"2020","unstructured":"Ge, S. et al. Discovery of secondary sulphonamides as IDO1 inhibitors with potent antitumor effects in vivo. J. Enzym. Inhib. Med. Chem. 35, 1240\u20131257 (2020).","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"3277_CR13","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.3389\/fimmu.2020.01185","volume":"11","author":"L Zhai","year":"2020","unstructured":"Zhai, L. et al. Immunosuppressive IDO in cancer: mechanisms of action, animal models, and targeting strategies. Front. Immunol. 11, 1185 (2020).","journal-title":"Front. Immunol."},{"key":"3277_CR14","doi-asserted-by":"publisher","first-page":"40486","DOI":"10.18632\/oncotarget.17119","volume":"8","author":"W Zhong","year":"2017","unstructured":"Zhong, W. et al. Indoleamine 2,3-dioxygenase 1 deficiency attenuates CCl4-induced fibrosis through Th17 cells down-regulation and tryptophan 2,3-dioxygenase compensation. Oncotarget 8, 40486\u201340500 (2017).","journal-title":"Oncotarget"},{"key":"3277_CR15","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.freeradbiomed.2020.01.009","volume":"152","author":"T Zeng","year":"2020","unstructured":"Zeng, T. et al. Indoleamine 2,3-dioxygenase 1enhanceshepatocytes ferroptosis in acute immune hepatitis associated with excess nitrative stress. Free Radic. Biol. Med. 152, 668\u2013679 (2020).","journal-title":"Free Radic. Biol. Med."},{"key":"3277_CR16","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1002\/pros.23808","volume":"79","author":"T Vidotto","year":"2019","unstructured":"Vidotto, T. et al. PTEN-deficient prostate cancer is associated with an immunosuppressive tumor microenvironment mediated by increased expression of IDO1 and infiltrating FoxP3+ T regulatory cells. Prostate 79, 969\u2013979 (2019).","journal-title":"Prostate"},{"key":"3277_CR17","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s13046-019-1083-5","volume":"38","author":"D Yang","year":"2019","unstructured":"Yang, D. et al. H (2)S suppresses indoleamine 2,3-dioxygenase 1 and exhibits immunotherapeutic efficacy in murine hepatocellular carcinoma. J. Exp. Clin. Cancer Res. 38, 88 (2019).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"3277_CR18","doi-asserted-by":"publisher","first-page":"14781","DOI":"10.18632\/oncotarget.7438","volume":"7","author":"Q Zhao","year":"2016","unstructured":"Zhao, Q. et al. Tumoral indoleamine 2,3-dioxygenase 1 is regulated by monocytes and T lymphocytes collaboration in hepatocellular carcinoma. Oncotarget 7, 14781\u201314790 (2016).","journal-title":"Oncotarget"},{"key":"3277_CR19","first-page":"4541","volume":"18","author":"Y Chen","year":"2019","unstructured":"Chen, Y. et al. Predictive value of plasmacytoid dendritic cells and Toll-like receptor-9 regarding the treatment efficacy of interferon-\u03b1 in HBeAg-positive chronic hepatitis B patients. Exp. Ther. Med. 18, 4541\u20134546 (2019).","journal-title":"Exp. Ther. Med."},{"key":"3277_CR20","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1002\/hep.30506","volume":"70","author":"J Cai","year":"2019","unstructured":"Cai, J., Zhang, X. J. & Li, H. The role of innate immune cells in nonalcoholic steatohepatitis. Hepatology 70, 1026\u20131037 (2019).","journal-title":"Hepatology"},{"key":"3277_CR21","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1002\/hep.24621","volume":"55","author":"J Jiao","year":"2012","unstructured":"Jiao, J. et al. Dendritic cell regulation of carbon tetrachloride-induced murine liver fibrosis regression. Hepatology 55, 244\u2013255 (2012).","journal-title":"Hepatology"},{"key":"3277_CR22","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1002\/hep.26267","volume":"58","author":"JR Henning","year":"2013","unstructured":"Henning, J. R. et al. Dendritic cells limit fibroinflammatory injury in nonalcoholic steatohepatitis in mice. Hepatology 58, 589\u2013602 (2013).","journal-title":"Hepatology"},{"key":"3277_CR23","first-page":"253191","volume":"2015","author":"S Trabanelli","year":"2015","unstructured":"Trabanelli, S. et al. PGE2-induced IDO1 inhibits the capacity of fully mature DCs to elicit an in vitro antileukemic immune response. J. Immunol. Res. 2015, 253191 (2015).","journal-title":"J. Immunol. Res."},{"key":"3277_CR24","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1039\/C7TX00194K","volume":"6","author":"Y Xie","year":"2017","unstructured":"Xie, Y. et al. Evaluation of the toxicity of iron-ion irradiation in murine bone marrow dendritic cells via increasing the expression of indoleamine 2,3-dioxygenase 1. Toxicol. Res. (Camb.) 6, 958\u2013968 (2017).","journal-title":"Toxicol. Res. (Camb.)"},{"key":"3277_CR25","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.molimm.2016.09.005","volume":"79","author":"N Na","year":"2016","unstructured":"Na, N. et al. Prolongation of kidney allograft survival regulated by indoleamine 2,3-dioxygenase in immature dendritic cells generated from recipient type bone marrow progenitors. Mol. Immunol. 79, 22\u201331 (2016).","journal-title":"Mol. Immunol."},{"key":"3277_CR26","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.3389\/fimmu.2020.01203","volume":"11","author":"Y Jiang","year":"2020","unstructured":"Jiang, Y., Que, W., Zhu, P. & Li, X. K. The role of diverse liver cells in liver transplantation tolerance. Front. Immunol. 11, 1203 (2020).","journal-title":"Front. Immunol."},{"key":"3277_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0073404","volume":"8","author":"J Nagano","year":"2013","unstructured":"Nagano, J. et al. Effects of indoleamine 2,3-dioxygenase deficiency on high-fat diet-induced hepatic inflammation. PLoS ONE 8, e73404 (2013).","journal-title":"PLoS ONE"},{"key":"3277_CR28","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1080\/713611034","volume":"33","author":"LW Weber","year":"2003","unstructured":"Weber, L. W., Boll, M. & Stampfl, A. Hepatotoxicity and mechanism of action of haloalkanes: carbon tetrachloride as a toxicological model. Crit. Rev. Toxicol. 33, 105\u2013136 (2003).","journal-title":"Crit. Rev. Toxicol."},{"key":"3277_CR29","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1002\/hep.1840030618","volume":"3","author":"J Bosch","year":"1983","unstructured":"Bosch, J., Enriquez, R., Groszmann, R. J. & Storer, E. H. Chronic bile duct ligation in the dog: hemodynamic characterization of a portal hypertensive model. Hepatology 3, 1002\u20131007 (1983).","journal-title":"Hepatology"},{"key":"3277_CR30","first-page":"305","volume":"65","author":"J Kountouras","year":"1984","unstructured":"Kountouras, J., Billing, B. H. & Scheuer, P. J. Prolonged bile duct obstruction: a new experimental model for cirrhosis in the rat. Br. J. Exp. Pathol. 65, 305\u2013311 (1984).","journal-title":"Br. J. Exp. Pathol."},{"key":"3277_CR31","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1111\/j.1530-0277.2011.01472.x","volume":"35","author":"E G\u00e4bele","year":"2011","unstructured":"G\u00e4bele, E. et al. A new model of interactive effects of alcohol and high-fat diet on hepatic fibrosis. Alcohol. Clin. Exp. Res. 35, 1361\u20131367 (2011).","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"3277_CR32","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1111\/cei.12586","volume":"180","author":"S Schulz","year":"2015","unstructured":"Schulz, S., Landi, A., Garg, R., Wilson, J. A. & van Drunen, L. D. H. S. Indolamine 2,3-dioxygenase expression by monocytes and dendritic cell populations in hepatitis C patients. Clin. Exp. Immunol. 180, 484\u2013498 (2015).","journal-title":"Clin. Exp. Immunol."},{"key":"3277_CR33","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.freeradbiomed.2020.07.038","volume":"160","author":"C Mo","year":"2020","unstructured":"Mo, C. et al. Mutual antagonism between indoleamine 2,3-dioxygenase 1 and nuclear factor E2-related factor 2 regulates the maturation status of DCs in liver fibrosis. Free Radic. Biol. Med. 160, 178\u2013190 (2020).","journal-title":"Free Radic. Biol. Med."},{"key":"3277_CR34","doi-asserted-by":"publisher","first-page":"153055","DOI":"10.1016\/j.phymed.2019.153055","volume":"63","author":"G Cao","year":"2019","unstructured":"Cao, G. et al. Danshensu, a novel indoleamine 2,3-dioxygenase1 inhibitor, exerts anti-hepatic fibrosis effects via inhibition of JAK2-STAT3 signaling. Phytomedicine 63, 153055 (2019).","journal-title":"Phytomedicine"},{"key":"3277_CR35","doi-asserted-by":"crossref","unstructured":"Keryakos, H., Mohammed, A. A., Higazi, A. M., Mahmoud, E. & Saad, Z. M. Serum and ascitic fluid interleukin-17 in spontaneous bacterial peritonitis in Egyptian patients with HCV-related liver cirrhosis. Curr. Res. Transl. Med. 4, 237\u2013243 (2020).","DOI":"10.1016\/j.retram.2020.03.001"},{"key":"3277_CR36","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1002\/hep.24764","volume":"55","author":"F Heymann","year":"2012","unstructured":"Heymann, F. et al. Hepatic macrophage migration and differentiation critical for liver fibrosis is mediated by the chemokine receptor C-C motif chemokine receptor 8 in mice. Hepatology 55, 898\u2013909 (2012).","journal-title":"Hepatology"},{"key":"3277_CR37","doi-asserted-by":"crossref","unstructured":"Pistulli, R. et al. Characterization of dendritic cells in human and experimental myocarditis. ESC Heart Fail. 7, 2305-2317 (2020).","DOI":"10.1002\/ehf2.12767"},{"key":"3277_CR38","doi-asserted-by":"publisher","unstructured":"Hayes, C. Cellular immunotherapies for cancer. Ir. J. Med. Sci. 1, 1\u201317 (2020) https:\/\/doi.org\/10.1007\/s11845-020-02264-w. Epub ahead of print. PMID: 32607912; PMCID: PMC7326625.","DOI":"10.1007\/s11845-020-02264-w"},{"key":"3277_CR39","doi-asserted-by":"publisher","first-page":"2598","DOI":"10.1080\/15384101.2019.1652471","volume":"18","author":"G Guo","year":"2019","unstructured":"Guo, G., Sun, L., Yang, L. & Xu, H. IDO1 depletion induces an anti-inflammatory response in macrophages in mice with chronic viral myocarditis. Cell Cycle 18, 2598\u20132613 (2019).","journal-title":"Cell Cycle"},{"key":"3277_CR40","doi-asserted-by":"publisher","unstructured":"Grunewald, M. E., Shaban, M. G., Mackin, S. R., Fehr, A. R. & Perlman, S. Murine coronavirus infection activates the aryl hydrocarbon receptor in an indoleamine 2,3-dioxygenase-independent manner, contributing to cytokine modulation and proviral TCDD-inducible-PARP expression. J. Virol. 94, e01743\u201319 (2020) https:\/\/doi.org\/10.1128\/JVI.01743-19. PMID: 31694960; PMCID: PMC7000979.","DOI":"10.1128\/JVI.01743-19"},{"key":"3277_CR41","doi-asserted-by":"publisher","first-page":"5238","DOI":"10.1111\/jcmm.15176","volume":"24","author":"X Feng","year":"2020","unstructured":"Feng, X. et al. A comprehensive analysis of IDO1 expression with tumour-infiltrating immune cells and mutation burden in gynaecologic and breast cancers. J. Cell. Mol. Med. 24, 5238\u20135248 (2020).","journal-title":"J. Cell. Mol. Med."},{"key":"3277_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-64847-y","volume":"10","author":"E Bahraoui","year":"2020","unstructured":"Bahraoui, E., Serrero, M. & Plan\u00e8s, R. HIV-1 Tat-TLR4\/MD2 interaction drives the expression of IDO-1 in monocytes derived dendritic cells through NF-\u03baB dependent pathway. Sci. Rep. 10, 8177 (2020).","journal-title":"Sci. Rep."},{"key":"3277_CR43","doi-asserted-by":"publisher","first-page":"1730538","DOI":"10.1080\/2162402X.2020.1730538","volume":"9","author":"M Georganaki","year":"2020","unstructured":"Georganaki, M. et al. Tumor endothelial cell up-regulation of IDO1 is an immunosuppressive feed-back mechanism that reduces the response to CD40-stimulating immunotherapy. Oncoimmunology 9, 1730538 (2020).","journal-title":"Oncoimmunology"},{"key":"3277_CR44","first-page":"4652596","volume":"2019","author":"Y Xu","year":"2019","unstructured":"Xu, Y. et al. Interleukin 10 gene-modified bone marrow-derived dendritic cells attenuate liver fibrosis in mice by inducing regulatory T cells and inhibiting the TGF-\u03b2\/Smad signaling pathway. Mediators Inflamm. 2019, 4652596 (2019).","journal-title":"Mediators Inflamm."},{"key":"3277_CR45","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.21037\/qims-19-849","volume":"10","author":"XP Wang","year":"2020","unstructured":"Wang, X. P. et al. Assessment of liver fibrosis with liver and spleen magnetic resonance elastography, serum markers in chronic liver disease. Quant. Imaging Med. Surg. 10, 1208\u20131222 (2020).","journal-title":"Quant. Imaging Med. Surg."},{"key":"3277_CR46","doi-asserted-by":"publisher","unstructured":"Abu, A. N. et al. Association between liver diffusion-weighted imaging apparent diffusion coefficient values and other measures of liver disease in pediatric autoimmune liver disease patients. Abdom Radiol (NY) (2020) https:\/\/doi.org\/10.1007\/s00261-020-02595-3. Epub ahead of print. PMID: 32462385.","DOI":"10.1007\/s00261-020-02595-3"},{"key":"3277_CR47","doi-asserted-by":"publisher","first-page":"106762","DOI":"10.1016\/j.intimp.2020.106762","volume":"86","author":"Z Zheng","year":"2020","unstructured":"Zheng, Z. et al. Splenectomy enhances the Ly6C(low) phenotype in hepatic macrophages by activating the ERK1\/2 pathway during liver fibrosis. Int. Immunopharmacol. 86, 106762 (2020).","journal-title":"Int. Immunopharmacol."},{"key":"3277_CR48","doi-asserted-by":"publisher","unstructured":"Crane, G. M., Liu, Y. C. & Chadburn, A. Spleen: development, anatomy and reactive lymphoid proliferations. Semin. Diagn. Pathol. S0740-2570, 30060-5 (2020) https:\/\/doi.org\/10.1053\/j.semdp.2020.06.003. Epub ahead of print. PMID: 32591155.","DOI":"10.1053\/j.semdp.2020.06.003"},{"key":"3277_CR49","doi-asserted-by":"publisher","unstructured":"Kashimura, M. The human spleen as the center of the blood defense system. Int. J. Hematol. 112, 147\u2013158 (2020) https:\/\/doi.org\/10.1007\/s12185-020-02912-y. Epub 2020 Jun 16. PMID: 32557229.","DOI":"10.1007\/s12185-020-02912-y"},{"key":"3277_CR50","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1002\/hep.26670","volume":"59","author":"Y Zhang","year":"2014","unstructured":"Zhang, Y. et al. Mesenchymal stem cells alleviate bacteria-induced liver injury in mice by inducing regulatory dendritic cells. Hepatology 59, 671\u2013682 (2014).","journal-title":"Hepatology"},{"key":"3277_CR51","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.3748\/wjg.v26.i10.1005","volume":"26","author":"DW Kurniawan","year":"2020","unstructured":"Kurniawan, D. W., Storm, G., Prakash, J. & Bansal, R. Role of spleen tyrosine kinase in liver diseases. World J. Gastroenterol. 26, 1005\u20131019 (2020).","journal-title":"World J. Gastroenterol."}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-03277-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-03277-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-03277-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T01:35:59Z","timestamp":1724290559000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-03277-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,7]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,1]]}},"alternative-id":["3277"],"URL":"https:\/\/doi.org\/10.1038\/s41419-020-03277-0","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,7]]},"assertion":[{"value":"15 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study did not include any human experiments. We certified that the use of all mice involved in this project, including the number of animals, species used, or procedures performed were carried out according to the provisions of the Animal Welfare Act, PHS Animal Welfare Policy, the principles of the \u201cNIH Guide for the Care and Use of Laboratory Animals,\u201d and approved by the National Institutional Animal Care and Ethical Committee of Guangzhou University of Chinese Medicine (S2017040, S2017043).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}}],"article-number":"16"}}